Top Markets
#1 ADO Protocol ADO Protocol +337.14%
#2 GoPlus Security GoPlus Security +57.08%
#3 Tutorial Tutorial +43.54%
#4 Nockchain Nockchain +38.56%
#5 Starpower Starpower +38.12%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#7 GAIB AID GAIB AID +24.67%
#8 The Black Bull The Black Bull +23.13%
#9 OpenEden OpenEden +15.63%
#10 Casper Network Casper Network +14.56%
Coin of the day
ADO Protocol ADO Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Traws Pharma, Inc. Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW
Rangering i aksjer #33205
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage,... Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
Aksjekurs
$0.54
Markedsverdi
$8.22M
Endring (1 dag)
-5.43%
Endring (1 år)
-64.24%
Land
US
Handel Traws Pharma, Inc. (TRAW)

Kategori

Healthcare
Aksjeprishistorikk for Traws Pharma, Inc. (TRAW)
Høyeste sluttskurs: $0.55 den 2026-08-01

Laveste sluttskurs: $1.18M den 2013-07-01
Aksjeprishistorikk for Traws Pharma, Inc. fra 2013 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -7.87%
2025 -73.19%
2024 -62.45%
2023 -1.12%
2022 -73.33%
2021 -51.96%
2020 16.11%
2019 -88.57%
2018 -87.09%
2017 -39.73%
2016 -78.39%
2015 -71.56%
2014 -71.82%
2013 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.73 30.79%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $993.55 51.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE